What are the potential hematological effects of leuprolide therapy, including changes in red or white blood cell counts, and how can these be monitored?
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Leuprolide can cause anemia by lowering red blood cell count. Monitoring involves regular CBC tests to track any changes in blood cell levels.
Leuprolide therapy may occasionally lead to decreased white blood cell counts, increasing infection risk. Periodic blood tests are recommended to assess hematological function.